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TITLE OF CASE  
 
Intracerebral haemorrhage in a dog with steroid responsive meningitis-arteritis. 
 
SUMMARY 
 
A 1 year 6 months old female neutered Boxer dog was presented with a four-day history of 
pyrexia, lethargy and neck pain. An intracerebral haemorrhage and a mediastinal mass were 
identified. Cerebrospinal fluid analysis revealed severe neutrophilic pleocytosis and steroid 
responsive meningitis-arteritis was suspected. A significant improvement was observed with 
immunosuppressive steroid therapy and subsequent imaging revealed a reduction in size of the 
intracerebral haemorrhage and disappearance of the mediastinal mass. Steroid responsive 
meningitis-arteritis is a systemic disease with potential involvement of multiple organs. 
Intracerebral haemorrhage can occur secondary to steroid responsive meningitis-arteritis and can 
have a successful outcome.  
 
BACKGROUND  
 
Steroid responsive meningitis-arteritis (SRMA) is the most frequently diagnosed inflammatory 
central nervous system disease of dogs (Fluehmann and others 2006) and is characterized by 
suppurative leptomeningitis and spinal arteritis (Harcourt 1978, Tipold and others 1995). 
It is a systemic disease with potential involvement of multiple organs (Navarro-Cubas and others 
2011, Tipold and others 1995, Snyder and others 1995), but the clinical and pathological 
manifestation of SRMA is predominantly neurological (Harcourt 1978, Tipold and others 1995, 
Tipold and Jaggy 1994, Lowrie and others 2009). Intraparenchymal central nervous system 
lesions secondary to SRMA are uncommon (Snyder and others 1995, Wrzosek and others 2009, 
Hughes and others 2015); and to the authors’ knowledge, an intracerebral haemorrhage secondary 
to SRMA has not been previously reported. 
 
CASE PRESENTATION  
 
A 1 year 6 months old female neutered Boxer dog was referred to the Neurology and 
Neurosurgery Service of Glasgow Small Animal Hospital with a four-day history of pyrexia, 
lethargy and neck pain. Treatment with tramadol, amoxicillin-clavulanic, and meloxicam was 
initiated by the referring veterinarian at onset of clinical signs with no significant improvement. 
Similar clinical signs occurred five months prior to presentation but resolved with a similar 
treatment.  
 
On physical examination the dog was lethargic and the neurological examination revealed a stiff 
gait and low head carriage. Severe discomfort was elicited on palpation of the thoracic vertebral 
column and flexion of the neck. During the examination, an episode of proprioceptive ataxia 
affecting all limbs, followed by collapse without loss consciousness that lasted approximately 
fifteen seconds was observed. The rest of the neurological examination was normal.  Based on 
history, signalment and the multifocal pain a lesion affecting the cervical and thoracic vertebral 
column was suspected. Additionally, to explain the episode of proprioceptive ataxia an 
intracranial lesion was considered.  
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INVESTIGATIONS  
 
Haematology, serum biochemistry, prothrombin and activated partial thromboplastin times, serial 
blood pressure measurements and echocardiography were within normal limits. Fibrinogen was 
increased (965mg/dl; reference range, 150-400). Toxoplasma gondii and Neospora caninum 
serum titres were negative. A faecal sample obtained for Baermann test was also negative. C-
reactive protein and urinalysis were not performed.  
 
Magnetic resonance imaging (MRI) of the brain and neck was performed using a 1.5-Tesla unit 
(Siemens Magnetom Essenza; Frimley). Turbo spin echo T1-weighted (T1W), fluid-attenuation 
inversion recovery (FLAIR), turbo spin echo T2-weighted (T2W) and T2* images of the head 
were acquired in the transverse plane. Sagittal and dorsal T2W images of the head and neck and 
sagittal T1W images of the head and neck were also obtained.  Post-contrast T1W images of the 
head were acquired in the sagittal and transverse planes; and postcontrast T1W images of the 
neck were acquired in the sagittal plane after intravenous administration of gadolinium 
(0.1mmol/kg; Gadovist, Bayer plc). MRI revealed an intra-axial oval-shape well-defined mass 
(3cm x 2cm x 1cm) located within the left olfactory bulb and frontal lobe causing mild mass 
effect with right-sided midline shift. The mass lesion was heterogeneously hyperintense on T2W 
and FLAIR images compared to grey matter, with a hyperintense periphery and isointense core on 
T1W images, and no contrast enhancement. The hyperintense periphery had a signal void on T2* 
images and the centre was hypointense in some areas and had a signal void in others. Surrounding 
the main lesion there was an ill-defined hyperintense T2W and FLAIR, and T1W isointense area 
consistent with perilesional oedema.  There was marked contrast enhancement of the 
leptomeninges surrounding the cerebrum (Fig. 1) and the cervical spinal cord (Fig. 2). There was 
also contrast enhancement of the longus colli muscles at the level of C3-C4 (Fig. 2).  
 
An oval-shaped well-defined mass (9cm x 3cm) located dorsally within the cranial mediastinum 
that displaced ventrally the trachea and the oesophagus was also identified. The mass had a T2W 
hypointense capsule and a T2W homogenously hyperintense and T1W isointense centre with a 
thin contrast medium-enhanced peripheral rim (Fig. 2). 
 
A Computed Tomography (CT) of the thorax and an ultrasound of the mediastinal mass (via a 
thoracic inlet window) and the abdomen were also performed. The abdominal ultrasound was 
normal. Ultrasonographically, the mass in the mediastinum (5.9cm x 4.4cm) was heterogeneous 
and was associated with multiple irregular anechoic areas, consistent with cystic, necrotic and/or 
hemorrhagic regions. Blood flow was not detected with colour flow Doppler and there were no 
reactive changes in the surrounding tissue. On CT the mass was well defined, slightly 
heterogeneous and had a soft tissue density. A fine needle aspirate could not be safely performed 
due to the relative position of the mass and the major blood vessels.  
 
A sample of cerebrospinal fluid (CSF) was collected from the cerebellomedullary cistern (c) and 
the lumbar region (l). Both samples revealed neutrophilic leucocytosis, (c-960 nucleated cells/μl 
and l-1360 nucleated cells/μl [reference range: <5]; consisting of 78-80% neutrophils, 10-14% 
lymphocytes and 2-6% macrophages, respectively), presence of red blood cells (c-24000/μl and l-
3340/μl [reference range: 0]) and increased total protein (c-136mg/dl and l-638.2mg/dl [reference 
range: <25 and <45 respectively]).  The neutrophils were not degenerated and no microorganisms 
were observed.  The presence of blood was likely the result of iatrogenic contamination. When 
applying protein concentration and leukocyte count correction formulas (1mg/dl or one white 
blood cell down every 1000 or 500  red blood cells respectively) values remain increased (c-
112mg/dl and l-634.2mg/dl; c-912 nucleated cells/μl and l-1353 nucleated cells/μl). 
 
DIFFERENTIAL DIAGNOSIS  
 
The main differential diagnosis taking into consideration the patient’s signalment, clinical signs, 
CSF analysis results and the MRI findings was a severe manifestation of SRMA with multiple 
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haemorrhages. Other differential diagnoses, such as infectious meningoencephalomyelitis were 
not fully excluded but were considered less likely.  
 
 
TREATMENT 
 
Treatment with 20mg/kg of oral metronidazole (Metrobactin, Dechra) every 12 hours for 7 days 
and 25mg/kg of oral amoxicillin-clavulanic acid (Clavaseptin, Vetoquinol) every 12 hours for 7 
days was initiated while waiting for CSF analysis results. During hospitalization and to control 
the severe pain, 0.3mg/kg of intravenous methadone (Comfortan, Dechra) every 4 hours for 2 
days and 0.02mg/kg intravenous buprenorphine (Vetergesic, Ceva Animal Health Ltd) every 6 
hours for 1 day after discontinuing treatment with methadone were administered. 
Immunosuppressive doses of oral prednisolone (Prednidale, Dechra) at 2mg/kg every 12 hours 
and 1mg/kg of oral omeprazole (Losec mups, AstraZeneca) every 24 hours for 7 days were 
initiated when the CSF analysis results were obtained. The dose of prednisolone was gradually 
decreased over a six months period as previously described (Lowrie and others 2009). 
 
OUTCOME AND FOLLOW-UP   
 
A significant improvement was observed and the dog was discharged five days after admission.  
 
The dog was re-examined two and eight weeks after diagnosis. Neurological examinations during 
both rechecks were normal and the owners reported a significant improvement. An ultrasound of 
the thoracic mass was performed at the first re-examination and revealed that the mass had 
reduced in size (1.5cm x 3.6cm) and appeared more homogeneous. Follow-up MRI at the second 
recheck revealed the mediastinal mass had disappeared and the olfactory bulb/frontal lobe mass 
had significantly reduced in size (1cm x 0.5cm). The mass was homogenously hypointense on 
T2W, FLAIR and T1W images with a signal void on T2* and no contrast enhancement (Fig. 3).  
 
The owners were contacted by phone 13 months after diagnosis. The dog had been normal for 10 
months and then had another episode of neck pain and pyrexia that resolved with another course 
of prednisolone using the same protocol (Lowrie and others 2009).  
 
DISCUSSION  
 
The aetiology is obscure, but SRMA is an immune-mediated disease. The lack of identifiable 
infectious organisms, response to treatment with steroids, high concentrations of immunoglobulin 
A (IgA) in the serum and CSF and increased interleukin 6 (IL-6) and transforming growth factor 
beta 1 (TGF-ß1) in CSF support this statement (Maiolini and others 2012, Rose and Harcourt-
Brown 2013, Biedermann and others 2016, Maiolini and others 2013). IL-6 and TGF-ß1  cause 
CD4 progenitors to differentiate towards a T helper (Th 17) and a recent study demonstrated that 
Th17 cells induce the autoimmune response in SRMA and are involved in the development of the 
severe neutrophilic pleocytosis and disruption of the blood brain barrier (Maiolini and others 
2013, Freundt-Revilla and others 2017).           
Although the clinical and pathological manifestation of SRMA is predominantly neurological 
(Harcourt 1978, Tipold and others 1995, Tipold and Jaggy 1994, Lowrie and others 2009), 
SRMA is a systemic disease with potential involvement of multiple organs (Tipold and others 
1995, Navarro-Cubas and others 2011, Snyder and others 1995).  Small to medium-sized 
muscular arteries of the heart, cranial mediastinum and cervical spinal cord are consistently 
involved and vasculitis occurs occasionally in other organs (Snyder and others 1995). The 
extracranial mass in this dog was possibly a hematoma located in the cranial mediastinum that 
disappeared following immunosuppression with steroids, supporting its possible relationship with 
SRMA.  
The mass was mainly located within the left olfactory lobe and may explain why no cranial nerve 
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or proprioceptive deficits were identified. The cause of the transient proprioceptive ataxia 
followed by collapse without loss consciousness is unknown, but the authors hypothesise it could 
be explained by quick changes in intracranial pressure secondary to the intracerebral 
haemorrhage. 
Intraparenchymal central nervous system lesions are uncommon with SRMA, but can occur. 
Massive extension of suppurative inflammation to the ventricles and the forebrain was reported in 
a boxer (Wrzosek and others 2009) and haemorrhage in the central canal of the cervical spinal 
cord with mild inflammatory infiltrate that occasionally extended into the superficial spinal cord 
parenchyma was reported in a coonhound (Hughes and others 2015).  Furthermore, some dogs 
with SRMA have proprioceptive deficits and/or gait abnormalities identified on clinical 
examination (Tipold and Jaggy 1994).  This could be due to spinal cord compression by enlarged 
vessels or tissue ischaemia secondary to vasculitis (Moore and Cupps 1983). Vacuolization of the 
white matter spinal tracts underlying the severely affected leptomeninges has been previously 
identified histopathologically in two cases (Snyder and others 1995).  
Dogs with non-traumatic intracranial haemorrhage are frequently diagnosed with concurrent 
medical conditions (Lowrie and others 2012). The presence of these conditions does not 
necessarily mean they were the cause of the haemorrhage, but a relationship is suspected in some 
cases. To the authors’ knowledge, this is the first report of intracerebral haemorrhage in a dog 
with SRMA. Despite being unspecific, measuring C-reactive protein could have provided further 
support of our presumptive diagnosis (Bathen-Noethen and others 2008).    
Focal suppurative inflammation with vascular changes and secondary haemorrhages has been 
previously identified on histopathology in the epidural outer layers of the dura matter and the 
epineurium of the spinal nerve roots of dogs with SRMA (Tipold and others 1995).  The 
meningeal haemorrhages can occasionally be extensive and affect the cerebrum, cerebellum and 
spinal cord (Hughes and others 2015). Thrombosis and dissolution of arterial wall integrity leads 
to haemorrhage and necrosis (Snyder and others 1995). This pathophysiological mechanism could 
have led to the formation of the intracerebral haemorrhage in our dog.  
The MRI signal for intracerebral haemorrhage is well documented and its appearance varies 
based on location, size, duration and source (due to alterations in blood haemoglobin) 
(Weingarten and others 1991, Zimmerman and others 1988, Taber and others 1996). The signal of 
the cerebral lesion during the first MRI varied between the centre and its periphery and this could 
represent different stages of clot formation. The signal of the lesion during the second MRI was 
compatible with a chronic haemorrhage (>14 days) (Weingarten and others 1991). The signal 
void observed on T2* sequences is not specific for haemorrhage and can be seen with 
mineralization, gas, fibrous tissue and iron deposits (Mulkern 2002). These were all considered 
less likely in this dog. Mild changes in cervical muscles were also identified; however, this can 
occur with inflammatory spinal cord disease (Eminaga and others 2013). The absence of an 
identifiable coagulopathy and other medical conditions suggested the cerebral haemorrhage 
possibly occurred secondary to the SRMA.  
 
The main limitation of this case report is the absence of histopathological confirmation. There is 
no definitive ante-mortem diagnostic test for SRMA and current diagnosis is based on clinical 
signs, laboratory findings and exclusion of other diseases (Lowrie and others 2012). Signalment, 
clinical signs (excluding the episode of collapse), CSF analysis results and response to treatment 
in our dog were characteristic of SRMA (Tipold and Jaggy 1994, Rose and Harcourt-Brown 
2013, Rose and others 2014, Cizinauskas and others 2000, Tipold and Schatzberg 2010). The 
clinical response to treatment with steroids, the absorption of the intracerebral haemorrhage and 
the mediastinal mass and the lack of more clinically significant haemorrhages during the follow-
up period, support the possible relationship of the intracerebral haemorrhage and the mediastinal 
mass with SRMA.   
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LEARNING POINTS/TAKE HOME MESSAGES  
 
 SRMA is a systemic disease with potential involvement of multiple organs.  
 Intracerebral haemorrhage can occur secondary to SRMA.  
 Outcome of cases with SRMA and secondary haemorrhages can be good.  
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FIGURE/VIDEO CAPTIONS  
 
Figure legends: 
 
Figure 1  
Transverse magnetic resonance images at the level of the olfactory lobes illustrating the suspected 
haemorrhage (arrow). The haemorrhage was heterogeneously hyperintense on T2W (A) and had a 
hypointense center and peripheral a signal void on T2* images (B). On T1W images the 
haemorrhage had a hyperintense periphery and isointense core (C) with no contrast enhancement 
(D).  
 
Figure 2 
Sagittal magnetic resonance images of the neck illustrating the oval-shaped well-defined mass 
located dorsally within the cranial mediastinum (large arrow) and the contrast enhancement of the 
cervical meninges (small arrow). The mass had a T2W hypointense capsule (A) and a T2W (A) 
homogenously hyperintense and T1W (B) isointense center with a peripheral thin ring of contrast 
uptake (C). 
 
Figure 3:  
Transverse magnetic resonance images at the level of the olfactory lobes illustrating reduction in 
size of the intracranial haemorrhage (arrow). The mass was homogenously hypointense on T2W 
(A), with a signal void on T2* (B), homogenously hypointense on T1W images (C) and with no 
contrast enhancement (D).  
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